These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18632284)

  • 1. Mast cells and cancer--no longer just basic science.
    Galinsky DS; Nechushtan H
    Crit Rev Oncol Hematol; 2008 Nov; 68(2):115-30. PubMed ID: 18632284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complexity of the complicity of mast cells in cancer.
    Nechushtan H
    Int J Biochem Cell Biol; 2010 May; 42(5):551-4. PubMed ID: 20026421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of mast cells in tumor growth.
    Conti P; Castellani ML; Kempuraj D; Salini V; Vecchiet J; Tetè S; Mastrangelo F; Perrella A; De Lutiis MA; Tagen M; Theoharides TC
    Ann Clin Lab Sci; 2007; 37(4):315-22. PubMed ID: 18000287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cell: insight into remodeling a tumor microenvironment.
    Liu J; Zhang Y; Zhao J; Yang Z; Li D; Katirai F; Huang B
    Cancer Metastasis Rev; 2011 Jun; 30(2):177-84. PubMed ID: 21267769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dark side of mast cell-targeted therapy in prostate cancer.
    Pittoni P; Colombo MP
    Cancer Res; 2012 Feb; 72(4):831-5. PubMed ID: 22307838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cells: multifaceted immune cells with diverse roles in health and disease.
    Rao KN; Brown MA
    Ann N Y Acad Sci; 2008 Nov; 1143():83-104. PubMed ID: 19076346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis.
    Fleischmann A; Schlomm T; Köllermann J; Sekulic N; Huland H; Mirlacher M; Sauter G; Simon R; Erbersdobler A
    Prostate; 2009 Jun; 69(9):976-81. PubMed ID: 19274666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAS: target for cancer therapy.
    Saxena N; Lahiri SS; Hambarde S; Tripathi RP
    Cancer Invest; 2008 Nov; 26(9):948-55. PubMed ID: 18798058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
    Shojaei F; Ferrara N
    Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple action agents and the eye: do they really stabilize mast cells?
    Lambiase A; Micera A; Bonini S
    Curr Opin Allergy Clin Immunol; 2009 Oct; 9(5):454-65. PubMed ID: 19652595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of therapeutic approaches to gastric cancer.
    Wu K; Nie Y; Guo C; Chen Y; Ding J; Fan D
    J Gastroenterol Hepatol; 2009 Jan; 24(1):37-41. PubMed ID: 19196394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cells as therapeutic target in cancer.
    Ribatti D
    Eur J Pharmacol; 2016 May; 778():152-7. PubMed ID: 25917325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyps wrap mast cells and Treg within tumorigenic tentacles.
    Colombo MP; Piconese S
    Cancer Res; 2009 Jul; 69(14):5619-22. PubMed ID: 19567669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cell contribution to tumor angiogenesis: a clinical approach.
    Crivellato E; Nico B; Ribatti D
    Eur Cytokine Netw; 2009 Dec; 20(4):197-206. PubMed ID: 20167559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of histone deacetylase inhibitors as new drugs for the treatment of inflammatory diseases and cancer.
    Glauben R; Siegmund B
    Methods Mol Biol; 2009; 512():365-76. PubMed ID: 19347289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cells in neoangiogenesis.
    Nienartowicz A; Sobaniec-Łotowska ME; Jarocka-Cyrta E; Lemancewicz D
    Med Sci Monit; 2006 Mar; 12(3):RA53-6. PubMed ID: 16501434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitors: apoptotic effects and clinical implications (Review).
    Emanuele S; Lauricella M; Tesoriere G
    Int J Oncol; 2008 Oct; 33(4):637-46. PubMed ID: 18813776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of mast cells in atopy: what can we learn from canine models? A thorough review of the biology of mast cells in canine and human systems.
    de Mora F; Puigdemont A; Torres R
    Br J Dermatol; 2006 Dec; 155(6):1109-23. PubMed ID: 17107377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effect of leaves of Eriobotrya japonica correlating with attenuation of p38 MAPK, ERK, and NF-kappaB activation in mast cells.
    Kim SH; Shin TY
    Toxicol In Vitro; 2009 Oct; 23(7):1215-9. PubMed ID: 19665545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chapter 6. Mouse models to investigate anti-cancer effects of VEGF inhibitors.
    Crawford Y; Ferrara N
    Methods Enzymol; 2008; 445():125-39. PubMed ID: 19022058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.